Test directory: Donor Specific Ab ID Class I and II

Ordering Code 8023
Test Name Donor Specific Ab ID Class I and II
Alias Donor Specific Ab Identification Class I and Class II
Preferred Specimen Whole Blood
Preferred Container No Additive, Glass (Red)
Optimum Volume 7 mL
Collection Instructions Draw full tube.
Handling Instructions Do NOT centrifuge specimen.
Transport Requirements Oahu: Refrigerated
Airline: Refrigerated
Specimen Stability Ambient: Not Stable
Refrigerated: 7 Days
Frozen: Not Stable
Rejection Criteria Frozen, Hemolyzed, Heparinized, Specimen older than stability limits, Under filled tube, Labeled incorrectly,
Plastic Red Top tube with additive received
Avail. Stat NO
Analytic Time 14 Days
Methodology Microarray Flow Analysis
Reference Lab  Eurofins, Donor and Product Testing

Reference range(s)

The reference ranges listed below are valid on this date of May 9, 2025.
Component Age Male Norm Male Critical Low Male Critical High Female Norm Female Critical High Female Critical Low Units Add'l info
DSA Testing Results ALL

DSA results...
DSA results are reported in MFI
Class I and Class II HLA Antibody testing by microarray flow analysis
DSA are assigned for antibody specificities with 1000 MFI or higher for HLA-A, -B, -DR, and -DQ; 2000 MFI or higher for HLA-C and -DP

See report.
Note1
A-DSA I-II ALL

Class I and...
Class I and Class II HLA Antibody testing by microarray flow analysis

Strong Antibody >=5000 MFI
Moderate Antibody 3500-4999 MFI
Weak Antibody 2000-3499 MFI
These tests were developed and their performance characteristics determined by Eurofins
DPT-Honolulu. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research
This laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing

See report.
Note2
A-LumSAB I ALL See report.
A-LumSAB II ALL See report.

Note1:


DSA results are reported in MFI
Class I and Class II HLA Antibody testing by microarray flow analysis
DSA are assigned for antibody specificities with 1000 MFI or higher for HLA-A, -B, -DR, and -DQ; 2000 MFI or higher for HLA-C and -DP

See report..

Note2:


Class I and Class II HLA Antibody testing by microarray flow analysis

Strong Antibody >=5000 MFI
Moderate Antibody 3500-4999 MFI
Weak Antibody 2000-3499 MFI
These tests were developed and their performance characteristics determined by Eurofins
DPT-Honolulu. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research
This laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing

See report..